Search research articles
Contact Us
Filters
Showing results (171-180 of 179) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 179 results.
Trends in Biochemical Sciences
|
June 22, 2002
P450 BM3: the very model of a modern flavocytochrome
Andrew W Munro, David G Leys, Kirsty J McLean, et al.
Chemical Science
|
March 7, 2017
Design and engineering of water-soluble light-harvesting protein maquettes
Goutham Kodali, Joshua A Mancini, Lee A Solomon, et al.
Journal of the American Chemical Society
|
July 17, 2020
A Thermostable Protein Matrix for Spectroscopic Analysis of Organic Semiconductors
George A Sutherland, Daniel Polak, David J K Swainsbury, et al.
The Lancet. Neurology
|
July 21, 2023
Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial
George Maynard, Ramakrishnan Kannan, Jian Liu, et al.
The Journal of Biological Chemistry
|
March 22, 2018
Probing the quality control mechanism of the <i>Escherichia coli</i> twin-arginine translocase with folding variants of a <i>de novo</i>-designed heme protein
George A Sutherland, Katie J Grayson, Nathan B P Adams, et al.
Journal of Medicinal Chemistry
|
November 9, 2010
Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist
Colin P Leslie, Matteo Biagetti, Silvia Bison, et al.
Nature Chemical Biology
|
October 15, 2013
Elementary tetrahelical protein design for diverse oxidoreductase functions
Tammer A Farid, Goutham Kodali, Lee A Solomon, et al.
Journal of Medicinal Chemistry
|
July 2, 2010
Design and synthesis of novel tricyclic benzoxazines as potent 5-HT(1A/B/D) receptor antagonists leading to the discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045)
Steven M Bromidge, Roberto Arban, Barbara Bertani, et al.
Biochemical Society Transactions
|
May 24, 2012
Engineering oxidoreductases: maquette proteins designed from scratch
Bruce R Lichtenstein, Tammer A Farid, Goutham Kodali, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 179) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 179 results.
Trends in Biochemical Sciences
|
June 22, 2002
P450 BM3: the very model of a modern flavocytochrome
Andrew W Munro, David G Leys, Kirsty J McLean, et al.
Chemical Science
|
March 7, 2017
Design and engineering of water-soluble light-harvesting protein maquettes
Goutham Kodali, Joshua A Mancini, Lee A Solomon, et al.
Journal of the American Chemical Society
|
July 17, 2020
A Thermostable Protein Matrix for Spectroscopic Analysis of Organic Semiconductors
George A Sutherland, Daniel Polak, David J K Swainsbury, et al.
The Lancet. Neurology
|
July 21, 2023
Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial
George Maynard, Ramakrishnan Kannan, Jian Liu, et al.
The Journal of Biological Chemistry
|
March 22, 2018
Probing the quality control mechanism of the <i>Escherichia coli</i> twin-arginine translocase with folding variants of a <i>de novo</i>-designed heme protein
George A Sutherland, Katie J Grayson, Nathan B P Adams, et al.
Journal of Medicinal Chemistry
|
November 9, 2010
Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist
Colin P Leslie, Matteo Biagetti, Silvia Bison, et al.
Nature Chemical Biology
|
October 15, 2013
Elementary tetrahelical protein design for diverse oxidoreductase functions
Tammer A Farid, Goutham Kodali, Lee A Solomon, et al.
Journal of Medicinal Chemistry
|
July 2, 2010
Design and synthesis of novel tricyclic benzoxazines as potent 5-HT(1A/B/D) receptor antagonists leading to the discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045)
Steven M Bromidge, Roberto Arban, Barbara Bertani, et al.
Biochemical Society Transactions
|
May 24, 2012
Engineering oxidoreductases: maquette proteins designed from scratch
Bruce R Lichtenstein, Tammer A Farid, Goutham Kodali, et al.
Page
of 18